Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatments for idiopathic granulomatous mastitis
IRCT20160101025791N3Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Oct 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of prednisolone, methotrexate and folic acid in Granulomatous lobular mastitis (GLM) (3 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Response to treatment. Started Oct 2018; status: completed.
02
Drugs
prednisolonemethotrexatefolic acid
03
Conditions
Granulomatous lobular mastitis (GLM)
Beyond the preview
Go deeper on IRCT20160101025791N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160101025791N3.